BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Icard P, Simula L, Wu Z, Berzan D, Sogni P, Dohan A, Dautry R, Coquerel A, Lincet H, Loi M, Fuks D. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? Drug Resist Updat 2021;:100790. [PMID: 34924279 DOI: 10.1016/j.drup.2021.100790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo X, Gao C, Yang DH, Li S. Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance. Drug Resist Updat 2023;67:100937. [PMID: 36753923 DOI: 10.1016/j.drup.2023.100937] [Reference Citation Analysis]
2 Kuok C, Wang Q, Fong P, Qin Y, Meng L. Inhibitory Effect of Hernandezine on the Proliferation of Hepatocellular Carcinoma. Biol Pharm Bull 2023;46:245-56. [PMID: 36724952 DOI: 10.1248/bpb.b22-00612] [Reference Citation Analysis]
3 Tian LY, Smit DJ, Jücker M. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int J Mol Sci 2023;24. [PMID: 36768977 DOI: 10.3390/ijms24032652] [Reference Citation Analysis]
4 Baker SA, Rutter J. Metabolites as signalling molecules. Nat Rev Mol Cell Biol 2023. [PMID: 36635456 DOI: 10.1038/s41580-022-00572-w] [Reference Citation Analysis]
5 Akhtar MJ, Khan SA, Kumar B, Chawla P, Bhatia R, Singh K. Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04618-7] [Reference Citation Analysis]
6 Wen GM, Xu XY, Xia P. Metabolism in Cancer Stem Cells: Targets for Clinical Treatment. Cells 2022;11. [PMID: 36497050 DOI: 10.3390/cells11233790] [Reference Citation Analysis]
7 Parkinson EK, Haferkamp S, Mycielska ME. Cancer Cell Metabolism. Int J Mol Sci 2022;23:7210. [PMID: 35806215 DOI: 10.3390/ijms23137210] [Reference Citation Analysis]